Panel: What we would do if 20% of our patent budget were cut

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Panel: What we would do if 20% of our patent budget were cut

Speakers discuss best patent budget practices

An all in-house panel explained how they stick to a budget and demonstrate the value of their patent portfolios

Panellists from InterDigital and Corteva Agriscience discussed best practices for patent budgets at Managing IP’s US Patent Forum yesterday.

Sonja London, director of patent licensing at Nokia in Finland, moderated the talk on “Portfolio optimisation: creative solutions for managing your IP strategy” and asked panellists what they would do if 20% of their budget were cut.

Marian Flattery, associate general counsel of IP at agricultural chemical company Corteva Agriscience in Iowa, said foreign filings would be the first area she would look to cut. She noted that her company often files in 40 to 60 countries, but said this could be curtailed if budget restrictions required it.

She added that Corteva has used a reverse auction platform to get law firms to bid against each other to work for the company. She said the process drove down costs by 25%, which was much more than she had expected.

Timothy Bedard, vice president and chief patent counsel at Visa in Washington DC but speaking in a personal capacity, said companies should consider subscription models where businesses pay law firms a certain amount of money per a month. 

He added that finance teams typically don’t like the “lumpiness” of legal expenses, so they may prefer more predictability.

Pruning and culture

Brian Dorini, senior portfolio manager at InterDigital in New Jersey, said businesses should look into pruning older patents. They can sell part of their portfolio to reduce costs and generate some income, he said.

Flattery at Corteva added that companies should consider how their culture contributes to budget issues. Some companies have a culture of counting patents and trying to get as many as possible.

But Flattery says this mindset can drive the wrong behaviour from patent attorneys and the research and development team. If companies are merely counting patents, they might try to register five patents where one would suffice and be more cost-effective.

How to outsource

Counsel discussed what kind of preparation and prosecution work can be outsourced to private practice lawyers and what should be done in-house.

Bedard said this issue comes down to whether the business believes that this kind of work is a good use of in-house lawyers’ time.

He said he believes that outside counsel are the experts and have knowledge of case law and the USPTO that makes them best suited to handle day-to-day patent preparation and prosecution.

But some companies take a different approach. Flattery said Corteva used to outsource 80% of its work to outside counsel and now sends out closer to 20%. She said the business hired additional attorneys and patent agents to reduce reliance on private practice lawyers.

Licensing mythology

Flattery also discussed licensing, saying her company doesn’t do a lot of it. That being said, Corteva has a patent for a popular pet medication and licenses this patent and gets a substantial revenue stream in return.   

But sometimes people at the business cite this patent as a reason to be wary of abandoning other patents.

“We need to manage the mythology within the company. If we haven’t licensed it out within five or ten years, we take a hard look at whether we’re trying to license it or just sitting on it in the hope that someday somebody will come knock on our door.”

Bedard went on to talk about how companies can demonstrate the value of their portfolios. He said it can be difficult for lawyers to do this if their companies are acquiring patents for defensive purposes rather than for licensing. 

But he said the absence of inbound lawsuits from operating companies can help prove that a patent portfolio is valuable.

Cross-licensing opportunities can also help lawyers demonstrate value, he added, because companies typically don’t want to enter cross-licence agreements with businesses that don’t have strong portfolios.

October 7 was the final day of Managing IP’s two-day virtual patent forum. 

more from across site and SHARED ros bottom lb

More from across our site

Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Gift this article